NEW YORK (GenomeWeb) – Fluidigm, Sequenom, and Foundation Medicine each saw big drops in their share prices month over month in May, while, overall, stocks in the omics tools and molecular diagnostics spaces improved about 3 percent. 

For May, 21 of the 31 firms in the GenomeWeb Index saw gains in their share prices, paced by Exact Sciences, whose stock rose 29 percent month over month. Meanwhile, NanoString Technologies' stock increased almost 18 percent, while Illumina's stock was up about 12 percent. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.